Login / Signup

Are costs derived from diagnosis-related groups suitable for use in economic evaluations? A comparison across nine European countries in the European Healthcare and Social Cost Database.

Zuzana ŠpacírováDavid M EpsteinJaime Espín
Published in: The European journal of health economics : HEPAC : health economics in prevention and care (2022)
Analysts should evaluate carefully whether DRG costs or tariffs published in each country are appropriate for use in economic evaluation.
Keyphrases
  • healthcare
  • mental health
  • adverse drug
  • emergency department
  • systematic review
  • electronic health record
  • life cycle